Risperidone‐induced tardive dyskinesia and parkinsonism

[1]  D. Folks,et al.  The Omnibus Budget Reconciliation Act: impact on psychotropic drug use in long-term care facilities. , 2009, Perspectives in psychiatric care.

[2]  R. Bridgman,et al.  Risperidone-induced extrapyramidal reactions , 1995, The Lancet.

[3]  J. Addington,et al.  The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder. , 1995 .

[4]  I. McKeith,et al.  Neuroleptic sensitivity to risperidone in Lewy body dementia , 1995, The Lancet.

[5]  J. Feighner,et al.  Bupropion: a review of its mechanism of antidepressant activity. , 1995, The Journal of clinical psychiatry.

[6]  G. Chouinard.  Effects of Risperidone in Tardive Dyskinesia: An Analysis of the Canadian Multicenter Risperidone Study* , 1995, Journal of clinical psychopharmacology.

[7]  Howland Rh.  Biochemical and clinical effects of buspirone augmentation. , 1994 .

[8]  D. Owens.  The spectrum of depressive phenomena after spousal bereavement. , 1994 .

[9]  Robert Miller,et al.  Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia , 1993, Biological Psychiatry.

[10]  J. Jankovic,et al.  Cocaine‐related movement disorders , 1993, Movement disorders : official journal of the Movement Disorder Society.

[11]  A. Walters,et al.  Persistent movement disorders induced by buspirone , 1993, Movement disorders : official journal of the Movement Disorder Society.

[12]  C. Olanow,et al.  Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[13]  A. Strauss.  Oral dyskinesia associated with buspirone use in an elderly woman. , 1988, The Journal of clinical psychiatry.

[14]  J. Nutt,et al.  Buspirone in Parkinson's disease. , 1986, Clinical neuropharmacology.

[15]  E. Friedman,et al.  Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia. , 1983, The Journal of pharmacology and experimental therapeutics.